Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.04 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |